Axsome therapeutics CEO sells $5.4m in shares
NeutralFinancial Markets

The CEO of Axsome Therapeutics has sold $5.4 million worth of shares, which raises questions about the company's future direction and the CEO's confidence in its performance. Such transactions can often signal various strategic moves within a company, and investors will be keen to analyze the implications of this sale on Axsome's stock and overall market position.
— Curated by the World Pulse Now AI Editorial System